A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas have?
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas has 317 citations in the OpenAlex counts ScholarIQ stores.
When was A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas published?
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas has 2006 year in the ScholarIQ index.
What is the open-access status of A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas?
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas has hybrid oa status in the ScholarIQ index.
What is the DOI of A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas?
The DOI for A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas is on the source record.
What is the PMID of A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas?
The PMID for A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas is on the source record.
What is the OpenAlex record for A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas?
The OpenAlex for A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas is on the source record.